The Food and Drug Administration (FDA) performed a drug quality assurance inspection at Matheson Tri-Gas, Inc. in Holland on Feb. 11, according to information from the FDA’s website.
The inspection’s final report stated that Matheson Tri-Gas, Inc. was not required to make any changes to its management operations.
The FDA conducts regular inspections nationwide to assess whether facilities and products comply with FDA laws and regulations intended to safeguard public health. Findings from these inspections are shared publicly.
The FDA’s website describes the agency as being primarily responsible for overseeing the production and distribution of human and animal drugs, biological products, medical equipment and tobacco products to ensure safety and quality.
Information for this article was sourced from the U.S. Food and Drug Administration. The original data can be accessed here.
